-+ 0.00%
-+ 0.00%
-+ 0.00%

Moleculin Biotech Secures RAMPA Approval to Expand Phase 3 MIRACLE Clinical Trial into Georgia, Boosting Global Enrollment Efforts

Reuters·07/09/2025 12:35:50

Please log in to view news